Page last updated: 2024-09-04

gadolinium dtpa and Scleroderma, Limited

gadolinium dtpa has been researched along with Scleroderma, Limited in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Karabela, G; Katsifis, G; Kolovou, G; Koutsogeorgopoulou, L; Markousis-Mavrogenis, G; Mavrogeni, S; Noutsias, M; Plastiras, S; Raftakis, J; Stavropoulos, E	1

Other Studies

1 other study(ies) available for gadolinium dtpa and Scleroderma, Limited

Article	Year
Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. BMC cardiovascular disorders, 2017, 07-17, Volume: 17, Issue:1 Topics: Adult; Asymptomatic Diseases; Biomarkers; Blood Sedimentation; C-Reactive Protein; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Predictive Value of Tests; Scleroderma, Diffuse; Scleroderma, Limited; Time Factors; Treatment Outcome; Troponin T; Ventricular Function, Left; Ventricular Function, Right	2017

Article

Year

Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.

BMC cardiovascular disorders, 2017, 07-17, Volume: 17, Issue:1

Topics: Adult; Asymptomatic Diseases; Biomarkers; Blood Sedimentation; C-Reactive Protein; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Predictive Value of Tests; Scleroderma, Diffuse; Scleroderma, Limited; Time Factors; Treatment Outcome; Troponin T; Ventricular Function, Left; Ventricular Function, Right

2017